TUESDAY, Dec. 12, 2023 (HealthDay News) — Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies — a class called GLP-1 RAs — quitContinue Reading
MONDAY, Dec. 11, 2023 (HealthDay News) — Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows. A trial funded by Eli Lilly, the injected drug’s maker, found that “in patients with obesity or overweight, withdrawingContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users’ odds for colon cancer? New research suggests they might. All of these medications (and more) fall into a class of diabetes drugs known as glucagon-like peptide-1 receptorContinue Reading
THURSDAY, Dec. 7, 2023 (HealthDay News) — A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin,Continue Reading
WEDNESDAY, Nov. 29, 2023 (Healthday News) — The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report. Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps control appetiteContinue Reading
WEDNESDAY, Nov. 29, 2023 (HealthDay News) — People can walk away their risk of developing type 2 diabetes – but only if they walk fast enough, a new report finds. Folks who walk at least 2.5 miles an hour appear to have a significantly lower risk of type 2 diabetes,Continue Reading
TUESDAY, Nov. 14, 2023 (HealthDay News) — Women who don’t get enough sleep might have an increased risk of diabetes, an effect even more pronounced in postmenopausal females, a new study finds. Shortening sleep by just 90 minutes increased insulin resistance in women used to getting adequate sleep, researchers atContinue Reading
MONDAY, Nov. 13, 2023 (HealthDay News) — Young people who smoke and have prediabetes have triple the risk of suffering a stroke, a new study shows. Overall, hospitalized tobacco users with prediabetes had a 3.3 times higher risk that they were in the hospital due to a stroke, after researchersContinue Reading
FRIDAY, Nov. 10, 2023 (HealthDay News) — Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study, scientists found excessive insulin levels overstimulated pancreatic acinar cells, which produce digestiveContinue Reading
THURSDAY, Nov. 9, 2023 (HealthDay News) — A kinder, more thoughtful workplace can lead to better heart health among older employees, a new study finds. Older workers’ heart health risk factors decreased significantly when their office employed interventions designed to reduce work-family conflicts, researchers report in the Nov. 8 issueContinue Reading